OTCMKTS:LPHM Lee Pharmaceuticals (LPHM) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free LPHM Stock Alerts $0.10 0.00 (-0.90%) (As of 07/28/2023) Add Compare Share Share Today's Range$0.07▼$0.1250-Day Range N/A52-Week Range$0.01▼$0.40Volume172,800 shsAverage Volume54,707 shsMarket Capitalization$3.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesStock AnalysisHeadlines Get Lee Pharmaceuticals alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Lee Pharmaceuticals Stock (OTCMKTS:LPHM)Lee Pharmaceuticals, Inc., through its subsidiary, RONN Motor Group, Inc., focuses on the design and development, manufacture, marketing, and sale of all-electric, hydrogen-fuel cell, and zero-emission new energy vehicles (NEVs) in the United States, China, and internationally. It intends to offer hydrogen fuel cell NEVs, including sports cars, sedans, SUVs, trucks, and buses. The company was founded in 2013 and is based in Scottsdale, Arizona.Read More LPHM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LPHM Stock News HeadlinesApril 15, 2024 | msn.comSingapore PM Lee to hand power to successor Wong on May 15February 10, 2024 | nypost.com5th Kansas City Chiefs fan at party where 3 friends were later found frozen to death ID’d: reportMay 6, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.February 7, 2024 | reuters.comPatrick Lee | ReutersJanuary 3, 2024 | wsj.comGan & Lee Pharmaceuticals Co. Ltd. AJanuary 2, 2024 | msn.com3x NCAA Champion Spencer Lee Makes an Audacious Statement Regarding 1960’s Olympic MedalistNovember 21, 2023 | washingtonpost.comLee HockstaderNovember 4, 2023 | investing.comLee’s Pharmaceutical Holdings Ltd (0950)May 6, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.November 3, 2023 | wsj.comLee's Pharmaceutical Holdings Ltd.October 26, 2023 | latimes.comWendy LeeOctober 10, 2023 | investing.comGan & Lee Pharmaceuticals Co Ltd (603087)May 15, 2023 | washingtonpost.comMichael LeeSee More Headlines Receive LPHM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lee Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/05/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Staples Industry Toilet preparations Sub-IndustryN/A Current SymbolOTCMKTS:LPHM Previous SymbolOTCMKTS:LPHM CUSIPN/A CIK58411 Webwww.leepharmaceuticals.com Phone(307) 278-1360Fax626-442-6994Employees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares35,162,000Free Float15,823,000Market Cap$17,581.00 OptionableNot Optionable Beta669.91 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Ronal Ford (Age 69)Founder, CEO & Chairman Mr. C.G. Ryche (Age 54)Chief Marketing Officer Dr. Delun WangSr. VP of Manufacturing & EngineeringMr. Damon Kuhn (Age 60)Chief Product Engineer & Product Manufacturing Integration Ms. Sheila R. StewartChief Global Corp. StrategistKey CompetitorsTattooed ChefNASDAQ:TTCFQAlkaline WaterNASDAQ:WTERMusclePharmOTCMKTS:MSLPChina Marine Food GroupOTCMKTS:CMFONew World BrandsOTCMKTS:NWBDView All Competitors LPHM Stock Analysis - Frequently Asked Questions How have LPHM shares performed in 2024? Lee Pharmaceuticals' stock was trading at $0.0258 at the start of the year. Since then, LPHM shares have increased by 283.7% and is now trading at $0.0990. View the best growth stocks for 2024 here. How do I buy shares of Lee Pharmaceuticals? Shares of LPHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LPHM) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldDems have chosen Biden replacement?Paradigm PressMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lee Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.